Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| QNCX (Quince Therapeutics, Inc.) | -96.99% | -91.51% | -58.95% | -70.24% | NA | NA | NA | … | … |
Data as of 06/05/2026, Common starting date is 05/09/2019
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| QNCX (Quince Therapeutics, Inc.) | 05/09/2019 | 06/05/2026 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | -12.17 | -91.51 | -58.95 | -70.24 | NA | NA | NA | … | … | -96.99 | 79.14 | 78.10 | 64.84 | -94.95 | -54.57 | -50.52 | 70.69 |
| Sharpe Ratio | NA | -0.29 | -0.31 | -0.41 | NA | NA | NA | … | … | -0.21 | 0.99 | 0.88 | 0.70 | -1.10 | -0.31 | -0.56 | 1.19 |
| Standard Deviation(%) | NA | 329.13 | 199.94 | 178.44 | NA | NA | NA | … | … | 493.67 | 77.75 | 84.48 | 88.49 | 87.62 | 176.91 | 90.28 | 107.15 |
| Draw Down(%) | NA | 98.18 | 98.18 | 99.93 | NA | NA | NA | … | … | 97.75 | 57.79 | 61.43 | 51.96 | 95.77 | 90.56 | 61.69 | 56.16 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 06/05/2026, Common starting date is 05/09/2019
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| QNCX (Quince Therapeutics, Inc.) |
-80.72%
Aug 2021 – Aug 2024 |
-69.19%
Mar 2021 – Mar 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| QNCX (Quince Therapeutics, Inc.) |
73.90%
Dec 2022 – Dec 2025 |
-34.50%
Dec 2020 – Dec 2025 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart